High content cellular screening.
Over the past few years, high content screening has firmly established itself as a high-throughput technology for the analysis of microscopy-based cellular assays. In particular, it has opened new areas of cell biology for the large-scale analysis of cellular phenotypes and has enabled the application of increasingly sophisticated assays for large-scale genetic and compound screening, benefiting both the academic and pharmaceutical research environment.
Rausch
Oliver
O
UCB Celltech, Granta Park, Great Abington, Cambridge, CB1 6GS, UK. oliver.rausch@ucb-group.com
D001681:Biological Assay; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D064420:Drug-Related Side Effects and Adverse Reactions; D034622:RNA Interference; D043562:Receptors, G-Protein-Coupled / Q000187:drug effects
D043562:Receptors, G-Protein-Coupled